Entrada Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol: TRDA on Nasdaq
Industry: Pharmaceutical Preparations
Location: One Design Center Place, Suite 17 500, Boston, MA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+3.41M	96.7%	$14.84	+$50.6M
Sells	4	-118K	3.3%	$16.47	-$1.94M
Net	-2	+3.29M	93.3%		+$48.7M

Entrada Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
MPM BioVentures 2014, L.P.	10%+ Owner	$70.8M			Nov 2, 2021
Mpm Bioventures 2018, L.P.	10%+ Owner	$70.8M			Nov 2, 2021
Baker Bros. Advisors Lp	10%+ Owner	$45.8M	+$50M		Jun 25, 2024
Roche Holding Ltd	10%+ Owner	$45M			Nov 2, 2021
Redmile Group, LLC	10%+ Owner	$31.3M			Nov 2, 2021
5AM Ventures V, L.P.	10%+ Owner	$18.1M			Nov 2, 2021
Dipal Doshi	CEO, Director	$4.93M	-$141K	-2.79%	Sep 3, 2024
Natarajan Sethuraman	President, Research & Develop.	$3.22M	-$791K	-19.7%	Nov 11, 2024
Nathan J. Dowden	President & COO	$2M	-$512K	-20.4%	Sep 26, 2024
Peter S. Kim	Director	$1.58M	+$642K	+68.1%	Jun 13, 2024
Kory James Wentworth	Chief Financial Officer	$1.48M	-$492K	-25%	Nov 11, 2024
Nerissa Kreher	Chief Medical Officer	$640K			Sep 1, 2023
Bernhardt Zeiher	Director				Jun 13, 2024
Kush Parmar	Director, 10%+ Owner				Jun 13, 2024
Gina Chapman	Director				Jun 13, 2024
Todd Foley	Director, 10%+ Owner				Jun 2, 2022
John F. Crowley	Director				Jun 8, 2023
Mary Thistle	Director				Jun 13, 2024
Carole Nuechterlein	Director				Jun 2, 2022

Recent Insider Transactions by Companies or Individuals for Entrada Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.